{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T21:33:29Z","timestamp":1793309609152,"version":"4.5.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,11,7]],"date-time":"2022-11-07T00:00:00Z","timestamp":1667779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,11,7]],"date-time":"2022-11-07T00:00:00Z","timestamp":1667779200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["22K20884"],"award-info":[{"award-number":["22K20884"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Among several secreted glycoproteins belonging to the thrombospondin family, thrombospondin 2 (TSP2) is involved in various functions, including collagen\/fibrin formation. Liver\/serum TSP2 levels have been correlated to liver fibrosis stage and disease activity in nonalcoholic fatty liver disease. This study investigated whether serum TSP2 was associated with clinicopathological features in hepatitis C virus (HCV)-infected patients as well. A total of 350 patients with HCV who had undergone liver biopsy were retrospectively enrolled and divided into a discovery cohort (n\u2009=\u2009270) and a validation cohort (n\u2009=\u200980). In the discovery cohort, serum TSP2 levels were moderately correlated with both liver fibrosis stage (<jats:italic>r<\/jats:italic>\u2009=\u20090.426, P\u2009&lt;\u20090.0001) and activity grade (<jats:italic>r<\/jats:italic>\u2009=\u20090.435, P\u2009&lt;\u20090.0001). The area under the receiver operating characteristic curve of TSP2 for predicting severe fibrosis (\u2265\u2009F3) was 0.78 and comparable to or better than those of autotaxin (0.78), FIB-4 index (0.78), and APRI (0.76). The discovery cohort findings were closely replicated in the validation cohort. Moreover, comprehensive liver genetic analysis of HCV-infected patients confirmed that the expression of the <jats:italic>THBS2<\/jats:italic> gene encoding TSP2 was significantly higher in severely fibrotic F4 than in F1 patients. Circulating TSP2 levels may reflect the severity of hepatic fibrosis\/inflammation in HCV-infected patients.<\/jats:p>","DOI":"10.1038\/s41598-022-23357-9","type":"journal-article","created":{"date-parts":[[2022,11,7]],"date-time":"2022-11-07T16:06:57Z","timestamp":1667837217000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Circulating thrombospondin 2 levels reflect fibrosis severity and disease activity in HCV-infected patients"],"prefix":"10.1038","volume":"12","author":[{"given":"Takanobu","family":"Iwadare","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takefumi","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoo","family":"Yamazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shun-ichi","family":"Wakabayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taiki","family":"Okumura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sai P.","family":"Pydi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoyuki","family":"Nakajima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mai","family":"Iwaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayumi","family":"Sugiura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoru","family":"Joshita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Uehara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeji","family":"Umemura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,7]]},"reference":[{"key":"23357_CR1","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.jhep.2018.03.026","volume":"69","author":"European Association for the Study of the Liver","year":"2018","unstructured":"European Association for the Study of the Liver. EASL recommendations on treatment of hepatitis C 2018. J. Hepatol. 69, 461\u2013511 (2018).","journal-title":"J. Hepatol."},{"key":"23357_CR2","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1002\/hep.1840120409","volume":"12","author":"K Kiyosawa","year":"1990","unstructured":"Kiyosawa, K. et al. Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: Analysis by detection of antibody to hepatitis C virus. Hepatology 12, 671\u2013675. https:\/\/doi.org\/10.1002\/hep.1840120409 (1990).","journal-title":"Hepatology"},{"issue":"Suppl 19","key":"23357_CR3","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1007\/s00535-008-2251-0","volume":"44","author":"T Umemura","year":"2009","unstructured":"Umemura, T., Ichijo, T., Yoshizawa, K., Tanaka, E. & Kiyosawa, K. Epidemiology of hepatocellular carcinoma in Japan. J. Gastroenterol. 44(Suppl 19), 102\u2013107. https:\/\/doi.org\/10.1007\/s00535-008-2251-0 (2009).","journal-title":"J. Gastroenterol."},{"key":"23357_CR4","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1172\/JCI33594","volume":"118","author":"N Tanaka","year":"2008","unstructured":"Tanaka, N. et al. PPARalpha activation is essential for HCV core protein-induced hepatic steatosis and hepatocellular carcinoma in mice. J. Clin. Invest. 118, 683\u2013694. https:\/\/doi.org\/10.1172\/JCI33594 (2008).","journal-title":"J. Clin. Invest."},{"key":"23357_CR5","doi-asserted-by":"publisher","first-page":"528","DOI":"10.4254\/wjh.v5.i10.528","volume":"5","author":"R Zampino","year":"2013","unstructured":"Zampino, R. et al. Chronic HCV infection and inflammation: Clinical impact on hepatic and extra-hepatic manifestations. World J. Hepatol. 5, 528 (2013).","journal-title":"World J. Hepatol."},{"key":"23357_CR6","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1046\/j.1365-2249.2000.01274.x","volume":"121","author":"T Umemura","year":"2000","unstructured":"Umemura, T. et al. Analysis of T cell repertoire in the liver of patients with chronic hepatitis C. Clin. Exp. Immunol. 121, 120\u2013126. https:\/\/doi.org\/10.1046\/j.1365-2249.2000.01274.x (2000).","journal-title":"Clin. Exp. Immunol."},{"key":"23357_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines8040074","author":"A Sugiura","year":"2020","unstructured":"Sugiura, A. et al. Effectiveness of glecaprevir\/pibrentasvir for hepatitis C: Real-World experience and clinical features of retreatment cases. Biomedicines https:\/\/doi.org\/10.3390\/biomedicines8040074 (2020).","journal-title":"Biomedicines"},{"key":"23357_CR8","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1002\/cld.925","volume":"16","author":"CS Graham","year":"2020","unstructured":"Graham, C. S. The current status of US and global access to direct-acting antiviral regimens for hepatitis C virus infection. Clin. Liver Dis. 16, 16\u201319. https:\/\/doi.org\/10.1002\/cld.925 (2020).","journal-title":"Clin. Liver Dis."},{"key":"23357_CR9","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s12992-017-0297-6","volume":"13","author":"Y Assefa","year":"2017","unstructured":"Assefa, Y., Hill, P. S., Ulikpan, A. & Williams, O. D. Access to medicines and hepatitis C in Africa: Can tiered pricing and voluntary licencing assure universal access, health equity and fairness?. Glob. Health 13, 73. https:\/\/doi.org\/10.1186\/s12992-017-0297-6 (2017).","journal-title":"Glob. Health"},{"key":"23357_CR10","doi-asserted-by":"publisher","first-page":"2396","DOI":"10.1016\/j.bbagen.2014.01.013","volume":"1840","author":"NE Calabro","year":"2014","unstructured":"Calabro, N. E., Kristofik, N. J. & Kyriakides, T. R. Thrombospondin-2 and extracellular matrix assembly. Biochim. Biophys. Acta 1840, 2396\u20132402 (2014).","journal-title":"Biochim. Biophys. Acta"},{"key":"23357_CR11","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1111\/liv.14776","volume":"41","author":"T Kimura","year":"2021","unstructured":"Kimura, T. et al. Serum thrombospondin 2 is a novel predictor for the severity in the patients with NAFLD. Liver Int. 41, 505\u2013514 (2021).","journal-title":"Liver Int."},{"key":"23357_CR12","doi-asserted-by":"publisher","first-page":"2452","DOI":"10.1002\/hep.31995","volume":"74","author":"K Kozumi","year":"2021","unstructured":"Kozumi, K. et al. Transcriptomics identify thrombospondin-2 as a biomarker for NASH and advanced liver fibrosis. Hepatology 74, 2452\u20132466. https:\/\/doi.org\/10.1002\/hep.31995 (2021).","journal-title":"Hepatology"},{"key":"23357_CR13","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.2337\/dc21-0131","volume":"44","author":"CH Lee","year":"2021","unstructured":"Lee, C. H. et al. Circulating thrombospondin-2 as a novel fibrosis biomarker of nonalcoholic fatty liver disease in type 2 diabetes. Diabetes Care 44, 2089\u20132097. https:\/\/doi.org\/10.2337\/dc21-0131 (2021).","journal-title":"Diabetes Care"},{"key":"23357_CR14","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.gendis.2019.04.007","volume":"6","author":"B Ijaz","year":"2019","unstructured":"Ijaz, B. et al. HCV infection causes cirrhosis in human by step-wise regulation of host genes involved in cellular functioning and defense during fibrosis: Identification of bio-markers. Genes Dis. 6, 304\u2013317. https:\/\/doi.org\/10.1016\/j.gendis.2019.04.007 (2019).","journal-title":"Genes Dis."},{"key":"23357_CR15","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/1471-230X-11-91","volume":"11","author":"A Baranova","year":"2011","unstructured":"Baranova, A., Lal, P., Birerdinc, A. & Younossi, Z. M. Non-invasive markers for hepatic fibrosis. BMC Gastroenterol. 11, 91. https:\/\/doi.org\/10.1186\/1471-230X-11-91 (2011).","journal-title":"BMC Gastroenterol."},{"key":"23357_CR16","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1002\/hep.21669","volume":"46","author":"A Vallet-Pichard","year":"2007","unstructured":"Vallet-Pichard, A. et al. FIB-4: An inexpensive and accurate marker of fibrosis in HCV infection: Comparison with liver biopsy and fibrotest. Hepatology 46, 32\u201336. https:\/\/doi.org\/10.1002\/hep.21669 (2007).","journal-title":"Hepatology"},{"key":"23357_CR17","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.3390\/cells8101249","volume":"8","author":"M Khatun","year":"2019","unstructured":"Khatun, M. & Ray, R. B. Mechanisms underlying hepatitis C virus-associated hepatic fibrosis. Cells 8, 1249 (2019).","journal-title":"Cells"},{"key":"23357_CR18","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.3748\/wjg.v24.i11.1239","volume":"24","author":"N Fujimori","year":"2018","unstructured":"Fujimori, N. et al. Serum autotaxin levels are correlated with hepatic fibrosis and ballooning in patients with non-alcoholic fatty liver disease. World J. Gastroenterol. 24, 1239\u20131249. https:\/\/doi.org\/10.3748\/wjg.v24.i11.1239 (2018).","journal-title":"World J. Gastroenterol."},{"key":"23357_CR19","doi-asserted-by":"publisher","first-page":"46705","DOI":"10.1038\/srep46705","volume":"7","author":"T Yamazaki","year":"2017","unstructured":"Yamazaki, T. et al. Association of serum autotaxin levels with liver fibrosis in patients with chronic hepatitis C. Sci. Rep. 7, 46705. https:\/\/doi.org\/10.1038\/srep46705 (2017).","journal-title":"Sci. Rep."},{"key":"23357_CR20","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a009712","volume":"3","author":"JC Adams","year":"2011","unstructured":"Adams, J. C. & Lawler, J. The thrombospondins. Cold Spring Harb. Perspect. Biol. 3, a009712. https:\/\/doi.org\/10.1101\/cshperspect.a009712 (2011).","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"23357_CR21","doi-asserted-by":"publisher","first-page":"2014","DOI":"10.1016\/j.bbagen.2014.01.013","volume":"2396\u20132402","author":"NE Calabro","year":"1840","unstructured":"Calabro, N. E., Kristofik, N. J. & Kyriakides, T. R. Thrombospondin-2 and extracellular matrix assembly. Biochim. Biophys. Acta 2396\u20132402, 2014. https:\/\/doi.org\/10.1016\/j.bbagen.2014.01.013 (1840).","journal-title":"Biochim. Biophys. Acta"},{"key":"23357_CR22","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.matbio.2005.03.003","volume":"24","author":"S Lindert","year":"2005","unstructured":"Lindert, S. et al. Transdifferentiation-dependent expression of \u03b1-SMA in hepatic stellate cells does not involve TGF-\u03b2 pathways leading to coinduction of collagen type I and thrombospondin-2. Matrix Biol. 24, 198\u2013207 (2005).","journal-title":"Matrix Biol."},{"key":"23357_CR23","doi-asserted-by":"publisher","first-page":"5955","DOI":"10.2147\/JIR.S314747","volume":"14","author":"CH Hou","year":"2021","unstructured":"Hou, C. H., Tang, C. H., Chen, P. C. & Liu, J. F. Thrombospondin 2 promotes IL-6 production in osteoarthritis synovial fibroblasts via the PI3K\/AKT\/NF-kappaB pathway. J. Inflamm. Res. 14, 5955\u20135967. https:\/\/doi.org\/10.2147\/JIR.S314747 (2021).","journal-title":"J. Inflamm. Res."},{"key":"23357_CR24","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1002\/hep.20917","volume":"43","author":"T Umemura","year":"2006","unstructured":"Umemura, T. et al. Quantitative analysis of anti-hepatitis C virus antibody-secreting B cells in patients with chronic hepatitis C. Hepatology 43, 91\u201399. https:\/\/doi.org\/10.1002\/hep.20917 (2006).","journal-title":"Hepatology"},{"key":"23357_CR25","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1111\/hepr.13745","volume":"52","author":"N Fujimori","year":"2022","unstructured":"Fujimori, N. et al. 2-Step PLT16-AST44 method: Simplified liver fibrosis detection system in patients with non-alcoholic fatty liver disease. Hepatol. Res. 52, 352\u2013363. https:\/\/doi.org\/10.1111\/hepr.13745 (2022).","journal-title":"Hepatol. Res."},{"key":"23357_CR26","first-page":"986","volume":"36","author":"X Forns","year":"2002","unstructured":"Forns, X. et al. Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model. Hepatology 36, 986\u2013992 (2002).","journal-title":"Hepatology"},{"key":"23357_CR27","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1053\/jhep.2003.50346","volume":"38","author":"C-T Wai","year":"2003","unstructured":"Wai, C.-T. et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology 38, 518\u2013526 (2003).","journal-title":"Hepatology"},{"key":"23357_CR28","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1002\/hep.1840200104","volume":"20","author":"P Bedossa","year":"1994","unstructured":"FMCS Group & Bedossa, P. Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. Hepatology 20, 15\u201320 (1994).","journal-title":"Hepatology"},{"key":"23357_CR29","doi-asserted-by":"publisher","first-page":"2406","DOI":"10.1016\/j.jse.2020.03.009","volume":"29","author":"JR Tuttle","year":"2020","unstructured":"Tuttle, J. R. et al. The relationship of shoulder elevation strength to patient-reported outcome after anatomic total shoulder arthroplasty. J. Shoulder Elbow Surg. 29, 2406\u20132416. https:\/\/doi.org\/10.1016\/j.jse.2020.03.009 (2020).","journal-title":"J. Shoulder Elbow Surg."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-23357-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-23357-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-23357-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,7]],"date-time":"2022-11-07T16:24:21Z","timestamp":1667838261000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-23357-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,7]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["23357"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-23357-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,7]]},"assertion":[{"value":"27 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"18900"}}